Skip to content
10-Q

Quarterly Report

PROLOR BIOTECH, INC.

0001144204-12-043813

← back to feed
Filed
Aug 9, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Jul 31, 2012 63.41M sh
Capex Q2 2012 · Jun 30, 2012 $1.49M
Capex Q2 2012 · Jun 30, 2011 $527.52K
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$42.23M
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$6.19M
Stockholders Equity Q2 2012 · Jun 30, 2012 $42.62M
Stockholders Equity Q2 2012 · Dec 31, 2011 $12.52M
Current Liabilities Q2 2012 · Jun 30, 2012 $1.25M
Current Liabilities Q2 2012 · Dec 31, 2011 $2.22M
Current Assets Q2 2012 · Jun 30, 2012 $43M
Current Assets Q2 2012 · Dec 31, 2011 $13.83M
Total Assets Q2 2012 · Jun 30, 2012 $44.2M
Total Assets Q2 2012 · Dec 31, 2011 $15.02M
Sga Expense Q2 2012 · Jun 30, 2012 $18.75M
Sga Expense Q2 2012 · Jun 30, 2011 $877.96K
Sga Expense Q2 2012 · Jun 30, 2011 $1.59M
Net Income Q2 2012 · Jun 30, 2012 −$57.72M
Net Income Q2 2012 · Jun 30, 2011 −$3.09M
Net Income Q2 2012 · Jun 30, 2011 −$6.56M
Operating Income Q2 2012 · Jun 30, 2012 −$58.15M
Operating Income Q2 2012 · Jun 30, 2011 −$3.26M
Operating Income Q2 2012 · Jun 30, 2011 −$7M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $16.01M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $24.47M